RGNX Latest Headlines

REGENXBIO sets October 20 investor event ahead of sura-vec wet AMD pivotal topline data expected in 4Q 2026

Market Chameleon (Tue, 13-Oct 11:16 AM)

RGNX schedules Oct. 20 investor event ahead of pivotal wet AMD topline data expected in 4Q 2026

Market Chameleon (Mon, 12-Oct 9:39 AM)

Regulatory Hold on REGENXBIO’s RGX-121 Shifts Focus to Duchenne and Retinal Therapies Amid Benign MRI Findings

Market Chameleon (Mon, 24-Aug 7:47 AM)

REGENXBIO Delivers Major Clinical Milestones and $22.7M Quarterly Net Income as Cash Runway Extends into Late 2027

Market Chameleon (Thu, 6-Aug 9:42 AM)